
Michael Inouye
scientistMale0.0Global Dominance: 0.00%
Professor Michael Inouye from the University of Cambridge is a key figure in cancer research, particularly in the application of genetic assessments for disease risk. He views the recent findings on a saliva test for prostate cancer as a landmark development in the field, but acknowledges that significant work remains before such tests can be routinely implemented in clinical settings.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Michael Inouye from the University of Cambridge believes the study is a landmark in using genetics to assess risks.
اختبار اللعاب يتفوق على الدم في كشف سرطان البروستاتاSabq·
Saudi Arabia· 2025-04-13
Prof Michael Inouye, from the University of Cambridge, believes the study will be seen as a landmark in using genetics to assess risk.
Saliva test may turn tide on prostate cancer claim scientistsBBC·
United Kingdom· 2025-04-10





